MedPath

Quality Of Life and Its Relation With Pharmaco-Epidemiological Variables Among Post Percuataneous Coronary Intervention Patients

Not Applicable
Conditions
Health Condition 1: I219- Acute myocardial infarction, unspecifiedHealth Condition 2: I229- Subsequent ST elevation (STEMI) myocardial infarction of unspecified site
Registration Number
CTRI/2021/09/036206
Lead Sponsor
SMS Medical College Jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

New Cases or patients who admitted first time for first Percutaneous Coronary Interventions (PCI) age of 45-65 Yrs., any gender, with or without any comorbidity will be included in the study.

Exclusion Criteria

Old cases or having Post Percutaneous Coronary Intervention status, Pregnant and lactating mothers.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To estimate the proportion of cases who has good quality of life after PCI Using short Seattle Angina Questionnaire 77 <br/ ><br>2. To determine the association of Pharmacoepidemiology variableâ??s with Quality of Life using WHO indicators including ICD and ATC classification, for drug utilizations in cases of Post Percutaneous coronary interventions <br/ ><br>3. To estimate adherence of Medicine in Post PCI cases using MMSA-48(Morisky Medication-Taking Adherence Scale-MMAS (4- item))Timepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
To sensitize the patients about appropriate use of Medications , Adverse Drugs Reactions and also report ADR if any to ADR monitoring center in Department of Pharmacology of SMS Medical College. <br/ ><br>â?¢ To sensitize the patients about risk factors and life style modifications <br/ ><br>â?¢ To calculate total number of defined daily dose (DDD) of each drug prescribed in Post PCI Patients.Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath